Complex treatment options of hip osteoarthritis

Abstract

Osteoarthritis has the highest prevalence among the musculoskeletal diseases in all economically developed countries. Despite the improvement of diagnostic and treatment methods, the number of patients with osteoarthritis is increasing. The number of cases of newly diagnosed osteoarthritis, cases of disease progression and subsequent disability are also growing. There are many guidelines for treatment of osteoarthritis, however, specialists have no consensus, especially regarding the amount and duration of conservative therapy.

The aim of the study was to analyze publications providing complex treatment options of hip osteoarthritis.

A systematic literature review has been conducted by means of the open acccess Pub-Med/MEDLINE database and eLibrary search for the period until January 2022. The search depth was 20 years and was performed by keywords and phrases: “hip joint osteoarthritis”, “conservative treatment”, “minimally invasive surgery”, “total hip arthroplasty”.

Unfortunately, the screening criteria for patients with osteoarthritis for total hip arthroplasty are not developed. The review analyzes the options of conservative therapy and minimally invasive surgical treatment for patients with osteoarthritis as the opportunity to avoid or delay the total hip replacement. The hip arthroplasty is not considered the “gold” standard; joint decision on surgery based on a comprehensive approach is made only when all the possibilities of conservative therapy are exhausted.

It is widely believed that complex treatment using modern conservative and organ-preserving methods is the most common strategy for managing osteoarthritis of the hip joint. This approach improves clinical and functional condition of patients and slows down the progression of the disease.

Keywords

hip joint osteoarthritis / conservative treatment / minimally invasive surgery / total hip arthroplasty

References

[1] Vina ER, Kwoh CK. Epidemiology of osteoarthritis: literature update. Opin Rheumatol. 2018;30(2):160–167. DOI: 10.1097/BOR.0000000000000479

[2] Vina E.R., Kwoh C.K. Epidemiology of osteoarthritis: literature update // Opin. Rheumatol. 2018. Vol. 30, No. 2. P. 160–167. DOI: 10.1097/BOR.0000000000000479

[3] De Frate LE, Kim-Wang SY, Englander ZA, Mc Nulty AL. Osteoarthritis year in review 2018: mechanics. Osteoarthritis Cartilage. 2019;27(3):392–400. DOI: 10.1016/j.joca.2018.12.011

[4] De Frate L.E., Kim-Wang S.Y., Englander Z.A., Mc Nulty A.L. Osteoarthritis year in review 2018: mechanics // Osteoarthritis Cartilage. 2019. Vol. 27, No. 3. P. 392–400. DOI: 10.1016/j.joca.2018.12.011

[5] Branco JC, Rodrigues AM, Gouveia N, et al. Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt — a national health survey. RMD Open. 2016;2(1):e000166. DOI: 10.1136/rmdopen-2015-000166

[6] Branco J.C., Rodrigues A.M., Gouveia N. et al. Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt — a national health survey // RMD Open. 2016. Vol. 2, No. 1. P. e000166. DOI: 10.1136/rmdopen-2015-000166

[7] Vorokov AA, Bortulev PI, Khaydarov VM, et al. Total hip and knee arthoplasty: on the issue of indications for surgery. Pediatric Traumatology, Orthopaedics, and Reconstructive Surgery. 2020;8(3):355–364. (In Russ.) DOI: 10.17816/PTORS34164

[8] Вороков А.А., Бортулев П.И., Хайдаров В.М. и др. Эндопротезирование тазобедренного и коленного суставов: показания к операции // Ортопедия, травматология и восстановительная хирургия детского возраста. 2020. Т. 8, № 3. С. 355–364. DOI: 10.17816/PTORS34164

[9] Burn E, Murray DW, Hawker GA. Lifetime risk of knee and hip replacement following a GP diagnosis of osteoarthritis: a real-world cohort study. Osteoarthritis Cartilage. 2019;27(11):1627–1635. DOI: 10.1016/j.joca.2019.06.004

[10] Burn E., Murray D.W., Hawker G.A. Lifetime risk of knee and hip replacement following a GP diagnosis of osteoarthritis: a real-world cohort study // Osteoarthritis Cartilage. 2019. Vol. 27, No. 11. P. 1627–1635. DOI: 10.1016/j.joca.2019.06.004

[11] Bruyère O, Honvo G, Veronese N. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337–350. DOI: 10.1016/j.semarthrit.2019.04.008

[12] Bruyère O., Honvo G., Veronese N. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) // Semin. Arthritis Rheum. 2019. Vol. 49, No. 3. P. 337–350. DOI: 10.1016/j.semarthrit.2019.04.008

[13] Bannuru RR, Osani MC, Vaysbrot EE. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–1589. DOI: 10.1016/j.joca.2019.06.011

[14] Bannuru R.R., Osani M.C., Vaysbrot E.E. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis // Osteoarthritis Cartilage. 2019. Vol. 27, No. 11. P. 1578–1589. DOI: 10.1016/j.joca.2019.06.011

[15] Favero M, Ramonda R, Goldring MB, et al. Early knee osteoarthritis. RMD Open. 2015;1(Suppl 1):e000062. DOI: 10.1136/rmdopen-2015-000062

[16] Favero M., Ramonda R., Goldring M.B. et al. Early knee osteoarthritis // RMD Open. 2015. Vol. 1, No. Suppl 1. P. e000062. DOI: 10.1136/rmdopen-2015-000062

[17] Filardo G, Kon E, Longo UG, et al. Non-surgical treatments for the management of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2016;24(6):1775–1785. DOI: 10.1007/s00167-016-4089-y

[18] Filardo G., Kon E., Longo U.G. et al. Non-surgical treatments for the management of early osteoarthritis // Knee Surg. Sports Traumatol. Arthrosc. 2016. Vol. 24, No. 6. P. 1775–1785. DOI: 10.1007/s00167-016-4089-y

[19] Lila AM, Alekseeva LI, Taskina EA. Modern approaches to osteoarthritis therapy taking into account updated international recommendations. Russian Medical Inquiry. 2019;3(11–2):48–52. (In Russ.)

[20] Лила А.М., Алексеева Л.И., Таскина Е.А. Современные подходы к терапии остеоартрита с учетом обновленных международных рекомендаций // Русский медицинский журнал. Медицинское обозрение. 2019. Т. 3, № 11–2. С. 48–52.

[21] Alekseeva LI, Naumov AV. Management of osteoarthritis with comorbidity in general medical practice (clinical recommendations). Doctor.ru. 2017;5(134):51–69. (In Russ.)

[22] Алексеева Л.И., Наумов А.В. Ведение остеоартрита с коморбидностью в общей врачебной практике (клинические рекомендации) // Доктор.ру. 2017. № 5(134). С. 51–69.

[23] Rausch Osthoff AK, Juhl CB, Knittle K, et al. Effects of exercise and physical activity promotion: meta-analysis informing the 2018 EULAR recommendations for physical activity in people with rheumatoid arthritis, spondyloarthritis and hip/knee osteoarthritis. RMD Open. 2018;4(2):e000713. DOI: 10.1136/rmdopen-2018-000713

[24] Rausch Osthoff A.K., Juhl C.B., Knittle K. et al. Effects of exercise and physical activity promotion: meta-analysis informing the 2018 EULAR recommendations for physical activity in people with rheumatoid arthritis, spondyloarthritis and hip/knee osteoarthritis // RMD Open. 2018. Vol. 4, No. 2. P. e000713. DOI: 10.1136/rmdopen-2018-000713

[25] Daste C, Kirren Q, Akoum J, et al. Physical activity for osteoarthritis: Efficiency and review of recommandations. Joint Bone Spine. 2021;88(6):105207. DOI: 10.1016/j.jbspin.2021.105207

[26] Daste C., Kirren Q., Akoum J. et al. Physical activity for osteoarthritis: Efficiency and review of recommandations // Joint Bone Spine. 2021. Vol. 88, No. 6. P. 105207. DOI: 10.1016/j.jbspin.2021.105207

[27] Abuseva GR, Kovlen DV, Ponomarenko GN, et al. Physical methods of rehabilitation of patients with osteoarthritis: scientometric analysis of evidence-based studies. Traumatology and Orthopedics of Russia. 2020;26(1):190–200. (In Russ.) DOI: 10.21823/2311-2905-2020-26-1-190-200

[28] Абусева Г.Р., Ковлен Д.В., Пономаренко Г.Н. и др. Физические методы реабилитации пациентов с остеоартрозом: наукометрический анализ доказательных исследований // Травматология и ортопедия России. 2020. № 26(1). С. 190–200. DOI: 10.21823/2311-2905-2020-26-1-190-200

[29] Drapkina OM, Skripnikova IA, Shepel RN, Kaburova AN. Osteoarthritis in the practice of a general practitioner: algorithm of diagnosis and choice of therapy. The Russian Journal of Preventive Medicine. 2018;21(6):12–22. (In Russ.) DOI: 10.17116/profmed20182106112

[30] Драпкина О.М., Скрипникова И.А., Шепель Р.Н., Кабурова А.Н. Оcтеоартрит в практике врача-терапевта: алгоритм диагностики и выбора терапии // Профилактическая медицина. 2018. Т. 21, № 6. С. 12–22. DOI: 10.17116/profmed20182106112

[31] Alekseeva LI, Lila AM. Osteoarthritis background therapy: current view on the glucosamine and chondroitin therapy. Modern Rheumatology Journal. 2021;15(2):112–119. (In Russ.) DOI: 10.14412/1996-7012-2021-2-112-119

[32] Алексеева Л.И., Лила А.М. Базисная терапия остеоартрита: современный взгляд на применение препаратов глюкозамина и хондроитина // Современная ревматология. 2021. Т. 15, № 2. С. 112–119. DOI: 10.14412/1996-7012-2021-2-112-119

[33] Majko OYu, Savelova EE. Clinical efficacy of chondroitin sulfate and its combination with glucosamine hydrochloride in the treatment of heart rose and coxarthrosis. Clinical Gerontology. 2016;22(5–6):18–25. (In Russ.)

[34] Майко О.Ю., Савелова Е.Е. Клиническая эффективность хондроитин сульфата и его комбинации с глюкозамина гидрохлоридом при лечении гонартроза и коксартроза в условиях поликлиники // Клиническая геронтология. 2016. Т. 22, № 5–6. С. 18–25.

[35] Henrotin Y, Mobasheri A, Marty M. Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? Arthritis Res Ther. 2012;14(1):201. DOI: 10.1186/ar3657

[36] Henrotin Y., Mobasheri A., Marty M. Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? // Arthritis Res. Ther. 2012. Vol. 14, No. 1. P. 201. DOI: 10.1186/ar3657

[37] Denisov LN, Platova AI, Menshikova IV, Lila AM. Osteoarthritis — aspects of pharmacotherapy. Modern Rheumatology Journal. 2018;12(2):97–102. (In Russ.) DOI: 10.14412/1996-7012-2018-2-97-102

[38] Денисов Л.Н., Платова А.И., Меншикова И.В., Лила А.М. Остеоартрит-аспекты фармакотерапии // Современная ревматология. 2018. Т. 12, № 2. С. 97–102. DOI: 10.14412/1996-7012-2018-2-97-102

[39] Gregori D, Giacovelli G, Minto C, et al. Association of Pharmacological Treatments with long-term pain control in patients with knee osteoarthritis: a systematic review and meta-analysis. JAMA. 2018;320(24):2564–2579. DOI: 10.1001/jama.2018.19319

[40] Gregori D., Giacovelli G., Minto C. et al. Association of Pharmacological Treatments with long-term pain control in patients with knee osteoarthritis: a systematic review and meta-analysis // JAMA. 2018. Vol. 320, No. 24. P. 2564–2579. DOI: 10.1001/jama.2018.19319

[41] Belyaeva IB, Mazurov VI, Raimuev KV. Current ESCEO recommendations for the treatment of osteoarthritis of the knee joint. Effective pharmacotherapy. 2018;(4):36–41. (In Russ.)

[42] Беляева И.Б., Мазуров В.И., Раймуев К.В. Актуальные рекомендации ESCEO по лечению остеоартрита коленного сустава // Эффективная фармакотерапия. 2018. № 4. С. 36–41.

[43] Kraus VB, Blanco FJ, Englund M, et al. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthritis Cartilage. 2015;23(8):1233–1241. DOI: 10.1016/j.joca.2015.03.036

[44] Kraus V.B., Blanco F.J., Englund M. et al. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use // Osteoarthritis Cartilage. 2015. Vol. 23, No. 8. P. 1233–1241. DOI: 10.1016/j.joca.2015.03.036

[45] Krylova IN, Tikhonov DA. Chondroprotectors (mechanism of action, efficiency and safety). Experimental and Clinical Pharmacology. 2018;81(7):39–44. (In Russ.) DOI: 10.30906/0869-2092-2018-81-7-39-44

[46] Крылова И.Н., Тихонов Д.А. Хондропротекторы (механизм действия, эффективность и безопасность) // Экспериментальная и клиническая фармакология. 2018. Т. 81, № 7. С. 39–44. DOI: 10.30906/0869-2092-2018-81-7-39-44

[47] Yang W, Sun C, He SQ, et al. The efficacy and safety of disease-modifying osteoarthritis drugs for knee and hip osteoarthritis — a systematic review and network meta-analysis. J Gen Intern Med. 2021;36(7):2085–2093. DOI: 10.1007/s11606-021-06755-z

[48] Yang W., Sun C., He S.Q. et al. The efficacy and safety of disease-modifying osteoarthritis drugs for knee and hip osteoarthritis — a systematic review and network meta-analysis // J. Gen. Intern. Med. 2021. Vol. 36, No. 7. P. 2085–2093. DOI: 10.1007/s11606-021-06755-z

[49] Uryasyev OM, Zaigrova NK. Osteoarthritis: pathogenesis, diagnosis, treatment. Zemsky doctor. 2016;(1–2(29–30)):27–35. (In Russ.)

[50] Урясьев О.М., Заигрова Н.К. Остеоартрит: патогенез, диагностика, лечение // Земский врач. 2016. № 1–2(29–30). С. 27–35.

[51] Bhala N, Emberson J, Merhi A, et al. Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769–779. DOI: 10.1016/S0140-6736(13)60900-9

[52] Bhala N., Emberson J., Merhi A. et al. Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials // Lancet. 2013. Vol. 382, No. 9894. P. 769–779. DOI: 10.1016/S0140-6736(13)60900-9

[53] Voronko IA. The place of hyaluronic acid preparations in the treatment of osteoarthritis. Medical news. 2018;2(281):24–28. (In Russ.)

[54] Воронько И.А. Место препаратов гиалуроновой кислоты в лечении остеоартрита // Медицинские новости. 2018. № 2(281). С. 24–28.

[55] Jüni P, Hari R, Rutjes AW, et al. Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev. 2015;2015(10):CD005328. DOI: 10.1002/14651858.cd005328.pub3

[56] Jüni P., Hari R., Rutjes A.W. et al. Intra-articular corticosteroid for knee osteoarthritis // Cochrane Database Syst. Rev. 2015. Vol. 2015, No. 10. P. CD005328. DOI: 10.1002/14651858.cd005328.pub3

[57] Gazendam A, Ekhtiari S, Bozzo A, et al. Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials. Br J Sports Med. 2021;55(5):256–261. DOI: 10.1136/bjsports-2020-102179

[58] Gazendam A., Ekhtiari S., Bozzo A. et al. Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials // Br. J. Sports Med. 2021. Vol. 55, No. 5. P. 256–261. DOI: 10.1136/bjsports-2020-102179

[59] Kandel L, Agar G, Elkayam O, et al. A novel approach for knee osteoarthritis using high molecular weight hyaluronic acid conjugated to plasma fibrinogen — interim findings of a double-blind clinical study. Heliyon. 2020;6(7):e04475. DOI: 10.1016/j.heliyon.2020.e04475

[60] Kandel L., Agar G., Elkayam O. et al. A novel approach for knee osteoarthritis using high molecular weight hyaluronic acid conjugated to plasma fibrinogen — interim findings of a double-blind clinical study // Heliyon. 2020. Vol. 6, No. 7. P. e04475. DOI: 10.1016/j.heliyon.2020.e04475

[61] Xie X, Zhang C, Tuan RS. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther. 2014;16(1):204. DOI: 10.1186/ar4493

[62] Xie X., Zhang C., Tuan R.S. Biology of platelet-rich plasma and its clinical application in cartilage repair // Arthritis Res. Ther. 2014. Vol. 16, No. 1. P. 204. DOI: 10.1186/ar4493

[63] Shen L, Yuan T, Chen S, et al. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res. 2017;12(1):16. DOI: 10.1186/s13018-017-0521-3

[64] Shen L., Yuan T., Chen S. et al. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials // J. Orthop. Surg. Res. 2017. Vol. 12, No. 1. P. 16. DOI: 10.1186/s13018-017-0521-3

[65] Citrome L, Weiss–Citrome AA. Systematic review of duloxetine for osteoarthritic pain: What is the number needed to treat, number needed to harm, and likelihood to be helped or harmed? Postgrad Med. 2012;124(1):83–93. DOI: 10.3810/pgm.2012.01.2521

[66] Citrome L., Weiss–Citrome A.A. Systematic review of duloxetine for osteoarthritic pain: What is the number needed to treat, number needed to harm, and likelihood to be helped or harmed? // Postgrad. Med. 2012. Vol. 124, No. 1. P. 83–93. DOI: 10.3810/pgm.2012.01.2521

[67] Kawarai Y, Orita S, Nakamura J, et al. Analgesic effect of duloxetine on an animal model of monosodium iodoacetate-induced hip osteoarthritis. J Orthop Res. 2020;38(2):422–430. DOI: 10.1002/jor.24480

[68] Kawarai Y., Orita S., Nakamura J. et al. Analgesic effect of duloxetine on an animal model of monosodium iodoacetate-induced hip osteoarthritis // J. Orthop. Res. 2020. Vol. 38, No. 2. P. 422–430. DOI: 10.1002/jor.24480

[69] Blikman T, Rienstra W, van Raaij TM. Duloxetine in OsteoArthritis (DOA) study: effects of duloxetine on pain and function in end-stage hip and knee OA — a pragmatic enriched randomized controlled trial. BMC Musculoskelet Disord. 2022;23(1):115. DOI: 10.1186/s12891-022-05034-0

[70] Blikman T., Rienstra W., van Raaij T.M. Duloxetine in OsteoArthritis (DOA) study: effects of duloxetine on pain and function in end-stage hip and knee OA — a pragmatic enriched randomized controlled trial // BMC Musculoskelet. Disord. 2022. Vol. 23, No. 1. P. 115. DOI: 10.1186/s12891-022-05034-0

[71] Zborovskaya IA, Mozgovaya EE, Bedina SA, et al. Osteoarthritis — a modern view of treatment. Lekarstvennyj vestnik. 2019;13(4(76)):7–15. (In Russ.)

[72] Зборовская И.А., Мозговая Е.Э., Бедина С.А. и др. Остеоартроз — современный взгляд на лечение // Лекарственный вестник. 2019. Т. 13, № 4(76). С. 7–15.

[73] Sarana AM, Krassiy AB, Golota AS, et al. Cellular technologies in the treatment of osteoarthritis of the hip joint: a review of registered clinical trials. Medical Alliance. 2021;(2):29–33. (In Russ.)

[74] Сарана А.М., Крассий А.Б., Голота А.С. и др. Клеточные технологии в лечении остеоартроза тазобедренного сустава: обзор зарегистрированных клинических испытаний // Медицинский Альянс. 2021. № 2. С. 29–33.

[75] Riddle DL, Jiranek WA, Hayes CW. Use of a validated algorithm to judge the appropriateness of total knee arthroplasty in the United States: a multicenter longitudinal cohort study. Arthritis Rheumatol. 2014;66(8):2134–2143. DOI: 10.1002/art.38685

[76] Riddle D.L., Jiranek W.A., Hayes C.W. Use of a validated algorithm to judge the appropriateness of total knee arthroplasty in the United States: a multicenter longitudinal cohort study // Arthritis Rheumatol. 2014. Vol. 66, No. 8. P. 2134–2143. DOI: 10.1002/art.38685

[77] Nazarov EA, Zubov AA, Ryabova MN, et al. Safe operations in the treatment of degenerative-dystrophic joint diseases or how to avoid arthroplasty? Proceedings of the conference “Achievements of Russian traumatology and orthopedics”. Saint Petersburg; 2018. P. 238–240. (In Russ.)

[78] Назаров Е.А., Зубов А.А., Рябова М.Н. и др. Сохранные операции в лечении дегенеративно-дистрофических заболеваний суставов или как избежать артропластики? // Материалы конференции «Достижения российской травматологии и ортопедии». Санкт-Петербург, 2018. С. 238–240.

[79] Solomin LN. Osnovy chreskostnogo osteosinteza. Moscow: BINOM; 2015. Vol. 2. P. 590–645. (In Russ.)

[80] Соломин Л.Н. Основы чрескостного остеосинтеза. Москва: БИНОМ, 2015. Т. 2, Гл. 8. C. 590–645.

[81] Paley D, Kocaoğlu M, Bilen FE. Combined technique: Correction of long bone deformities using fixator-assisted nailing. Springer: Berlin Heidelberg; 2015. P. 33–47. DOI: 10.1007/978-3-642-55026-3_2

[82] Paley D., Kocaoğlu M., Bilen F.E. Combined technique: Correction of long bone deformities using fixator-assisted nailing. Springer: Berlin Heidelberg, 2015. P. 33–47. DOI: 10.1007/978-3-642-55026-3_2

[83] Yadav AK, Parihar M, Pawar ED, et al. Functional outcome of high tibial osteotomy in patients with medial compartment osteoarthritis using dynamic axial fixator — a prospective study. J Clin Orthop Trauma. 2020;11(Suppl 5):S902–S908. DOI: 10.1016/j.jcot.2020.07.033

[84] Yadav A.K., Parihar M., Pawar E.D. et al. Functional outcome of high tibial osteotomy in patients with medial compartment osteoarthritis using dynamic axial fixator — a prospective study // J. Clin. Orthop. Trauma. 2020. Vol. 11, No. Suppl 5. P. S902–S908. DOI: 10.1016/j.jcot.2020.07.033

[85] Ross JR, Larson CM, Bedi A. Indications for hip arthroscopy. Sports Health. 2017;9(5):402–413. DOI: 10.1177/1941738117712675

[86] Ross J.R., Larson C.M., Bedi A. Indications for Hip Arthroscopy // Sports Health. 2017. Vol. 9, No. 5. P. 402–413. DOI: 10.1177/1941738117712675

[87] Yakupova ER. Possibilities of hip arthroscopy. In: Novoe slovo v nauke. Penza: Nauka i Prosveshchenie, 2020. Chapter 9. P. 109–119. (In Russ.)

[88] Якупова Е.Р. Возможности артроскопии тазобедренного сустава // Новое слово в науке. Пенза: Наука и Просвещение, 2020. Гл.9. С. 109–119.

[89] Jamil M, Dandachli W, Noordin S, Witt J. Hip arthroscopy: Indications, outcomes and complications. Int J Surg. 2018;54(Pt B):341–344. DOI: 10.1016/j.ijsu.2017.08.557

[90] Jamil M., Dandachli W., Noordin S., Witt J. Hip arthroscopy: Indications, outcomes and complications // Int. J. Surg. 2018. Vol. 54, No. Pt B. P. 341–344. DOI: 10.1016/j.ijsu.2017.08.557

[91] Volokitina EA, Kutepov SM, Gilev MV, et al. Kompleksnoe lechenie osteoartrita krupnykh sustavov: uchebno-metodicheskoe posobie. Ekaterinburg; 2020. (In Russ.)

[92] Волокитина Е.А., Кутепов С.М., Гилев М.В. и др. Комплексное лечение остеоартрита крупных суставов: учебно-методическое пособие. Екатеринбург, 2020.

[93] Gerasimov SA, Zykin AA, Korytkin AA, et al. Arthroscopic management of femoroacetabular impingement: evaluation of a two-year follow-up. Orthopaedic Genius. 2020;26(3):353–358. (In Russ.) DOI: 10.18019/1028-4427-2020-26-3-353-358

[94] Герасимов С.А., Зыкин А.А., Корыткин А.А. и др. Эффективность артроскопии тазобедренного сустава как метода хирургической коррекции фемороацетабулярного импинджмента. Оценка результатов лечения в течение двух лет после операции // Гений ортопедии. 2020. Т. 26, № 3. С. 353–358. DOI: 10.18019/1028-4427-2020-26-3-353-358

[95] Morattel B, Bonin N. Unusual apical femoral head deformity treated by hip arthroscopy and tunnel drilling through femoral head: a case report. J Hip Preserv Surg. 2021;8(Suppl 1):i25–i33. DOI: 10.1093/jhps/hnab026

[96] Morattel B., Bonin N. Unusual apical femoral head deformity treated by hip arthroscopy and tunnel drilling through femoral head: a case report // J. Hip Preserv. Surg. 2021. Vol. 8, No. Suppl 1. P. i25–i33. DOI: 10.1093/jhps/hnab026

[97] Bedard NA, Pugely AJ, Duchman KR, et al. When hip scopes fail, they do so quickly. J Arthroplasty. 2016;31(6):1183–1187. DOI: 10.1016/j.arth.2015.12.024

[98] Bedard N.A., Pugely A.J., Duchman K.R. et al. When hip scopes fail, they do so quickly // J. Arthroplasty. 2016. Vol. 31, No. 6. P. 1183–1187. DOI: 10.1016/j.arth.2015.12.024

[99] Drobniewski M, Synder M, Skrzypek M, et al. Hip joint arthroscopy in professionally active patients with osteoarthritis. Int J Occup Med Environ Health. 2019;32(1):115–120. DOI: 10.13075/ijomeh.1896.01381

[100] Drobniewski M., Synder M., Skrzypek M. et al. Hip joint arthroscopy in professionally active patients with osteoarthritis // Int. J. Occup. Med. Environ. Health. 2019. Vol. 32, No. 1. P. 115–120. DOI: 10.13075/ijomeh.1896.01381

[101] Mardones R, Larrain C. Cartilage restoration technique of the hip. J Hip Preserv Surg. 2015;3(1):30–36. DOI: 10.1093/jhps/hnv061

[102] Mardones R., Larrain C. Cartilage restoration technique of the hip // J. Hip Preserv. Surg. 2015. Vol. 3, No. 1. P. 30–36. DOI: 10.1093/jhps/hnv061

[103] .Gilfanov SI, Semenov AI, Netsvetaev KE, Stepanova AI. Indications for arthroscopy of the central and peripheral parts of the hip joint. Kremlin Medical Journal. 2017;(4–2):96–102. (In Russ.)

[104] Гильфанов С.И., Семенов А.И., Нецветаев К.Е., Степанова А.И. Показания к артроскопии центрального и периферического отделов тазобедренного сустава // Кремлевская медицина. Клинический вестник. 2017. № 4–2. С. 96–102.

[105] Olyunin YuA. Osteoarthritis: modern principles of treatment and prerequisites for the development of personalized therapy. Modern Rheumatology Journal. 2016;10(3):81–86. (In Russ.) DOI: 10.14412/1996-7012-2016-3-81-86

[106] Олюнин Ю.А. Остеоартроз: современные принципы лечения и предпосылки для разработки персонифицированной терапии // Современная ревматология. 2016. Т. 10, № 3. С. 81–86. DOI: 10.14412/1996-7012-2016-3-81-86

[107] Zarringam D, Saris DBF, Bekkers JEJ. Identification of early prognostic factors for knee and hip arthroplasty; a long-term follow-up of the CHECK cohort. J Orthop. 2019;19:41–45. DOI: 10.1016/j.jor.2019.10.020

[108] Zarringam D., Saris D.B.F., Bekkers J.E.J. Identification of early prognostic factors for knee and hip arthroplasty; a long-term follow-up of the CHECK cohort // J. Orthop. 2019. Vol. 19. P. 41–45. DOI: 10.1016/j.jor.2019.10.020

[109] Vina ER, Ran D, Ashbeck EL, et al. Patient preferences for total knee replacement surgery: Relationship to clinical outcomes and stability of patient preferences over 2 years. Semin Arthritis Rheum. 2016;46(1):27–33. DOI: 10.1016/j.semarthrit.2016.03.012

[110] Vina E.R., Ran D., Ashbeck E.L. et al. Patient preferences for total knee replacement surgery: Relationship to clinical outcomes and stability of patient preferences over 2 years // Semin. Arthritis Rheum. 2016. Vol. 46, No. 1. P. 27–33. DOI: 10.1016/j.semarthrit.2016.03.012

[111] de Jesus C, Stacey D, Dervin GF Evaluation of a patient decision aid for unicompartmental or total knee arthroplasty for medial knee osteoarthritis. J Arthroplasty. 2017;32(11):3340–3344. DOI: 10.1016/j.arth.2017.06.014

[112] de Jesus C., Stacey D., Dervin G.F. Evaluation of a patient decision aid for unicompartmental or total knee arthroplasty for medial knee osteoarthritis // J. Arthroplasty. 2017. Vol. 32, No. 11. P. 3340–3344. DOI: 10.1016/j.arth.2017.06.014

[113] Cronström A, Dahlberg LE, Nero H, Hammarlund CS. “I was considering surgery because I believed that was how it was treated”: a qualitative study on willingness for joint surgery after completion of a digital management program for osteoarthritis. Osteoarthritis Cartilage. 2019;27(7):1026–1032. DOI: 10.1016/j.joca.2019.04.004

[114] Cronström A., Dahlberg L.E., Nero H., Hammarlund C.S. “I was considering surgery because I believed that was how it was treated”: a qualitative study on willingness for joint surgery after completion of a digital management program for osteoarthritis // Osteoarthritis Cartilage. 2019. Vol. 27, No. 7. P. 1026–1032. DOI: 10.1016/j.joca.2019.04.004

[115] Shukurova SM, Khamraeva ZD, Shodiev BR, Karimova GN. Osteoarthritis as an important problem of geriatrics. Avicenna Bulletin. 2016;1(66):137–143. (In Russ.)

[116] Шукурова С.М., Хамроева З.Д., Шодиев Б.Р., Каримова Г.Н. Остеоартроз как важная проблема гериатрии // Вестник Авиценны. 2016. № 1(66). С. 137–143.

[117] Austin DC, Torchia MT, Moschetti WE, et al. Patient outcomes after total hip arthroplasty in extreme elderly patients older than 80 years. Hip Int. 2020;30(4):407–416. DOI: 10.1177/1120700019837943

[118] Austin D.C., Torchia M.T., Moschetti W.E. et al. Patient outcomes after total hip arthroplasty in extreme elderly patients older than 80 years // Hip Int. 2020. Vol. 30, No. 4. P. 407–416. DOI: 10.1177/1120700019837943

[119] Kunkel ST, Sabatino MJ, Kang R, et al. The cost-effectiveness of total hip arthroplasty in patients 80 years of age and older. J Arthroplasty. 2018;33(5):1359–1367. DOI: 10.1016/j.arth.2017.11.063

[120] Kunkel S.T., Sabatino M.J., Kang R. et al. The cost-effectiveness of total hip arthroplasty in patients 80 years of age and older // J. Arthroplasty. 2018. Vol. 33, No. 5. P. 1359–1367. DOI: 10.1016/j.arth.2017.11.063

[121] Clinical recommendations — Coxarthrosis — 2021–2022–2023 [Internet]. Available from: http://disuria.ru/_ld/10/1086_kr21M16MZ.pdf. Accessed: June 28, 2022. (In Russ.)

[122] Клинические рекомендации — Коксартроз — 2021–2022–2023 [Электронный ресурс]. Режим доступа: http://disuria.ru/_ld/10/1086_kr21M16MZ.pdf. Дата обращения: 28.06.2022.

RIGHTS & PERMISSIONS

Eco-Vector